Factbites
 Where results make sense
About us   |   Why use us?   |   Reviews   |   PR   |   Contact us  

Topic: Harold Varmus


Related Topics

  
  Open and Shut?: Interview with Harold Varmus
Harold Varmus was born in 1939, on the south shore of Long Island, New York, a product, as he put it in an autobiographical note he wrote years later, of "the early twentieth century emigration of Eastern European Jewry to New York City and its environs."
In part to avoid the draft, Varmus applied for a research training post at the National Institutes of Health (NIH), where he was accepted for a clinical associate position in the laboratory of molecular biologist Ira Pastan.
In retrospect, Varmus agrees that he was naïve not to have anticipated the furore.
poynder.blogspot.com /2006/06/interview-with-harold-varmus.html   (4157 words)

  
  Columbia News ::: Nobel Laureate and Former NIH Head Harold Varmus Elected to University Trustees
Varmus, who spent 23 years as a faculty member at UCSF, Bishop and their co-workers demonstrated the cellular origins of the oncogene of a chicken retrovirus.
Varmus is also widely recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer and the development of mouse models for human cancer.
Varmus obtained his bachelor's degree in English from Amherst College, graduating magna cum laude in 1961, and a master's degree in English literature from Harvard in 1962.
www.columbia.edu /cu/news/02/09/haroldVarmus.html   (443 words)

  
 Harold Varmus discusses genetics, cancer   (Site not responding. Last check: 2007-10-15)
Varmus also explained that the "Kassebaum-Kennedy" bill, which President Clinton signed into law as the Health Insurance Portability and Accountability Act of 1996, prohibits the use of genetic information to discriminate against those who are insured.
Varmus has been director of the NIH, headquartered in Bethesda, Md., since November 1993, and he is the first Nobelist to serve as the agency's director.
Varmus also emphasized that genetic testing potentially will be able to warn those who have a predisposition to cancer, but it will not be able to identify those who will or will not acquire the disease.
www.news.cornell.edu /Chronicle/97/11.20.97/Varmus.html   (483 words)

  
 Harold Elliot Varmus (1939 - )   (Site not responding. Last check: 2007-10-15)
Harold Varmus was born in Oceanside, New York.
This research, conducted under the supervision of Varmus and Bishop at the University of California at San Francisco in the mid-seventies, has led to great strides in the understanding, diagnosis, and treatment of a variety of cancers.
Varmus and Bishop were celebrated by the Nobel committee in 1989 for the research they had done on oncogenes.
www.accessexcellence.org /AB/BC/Harold_Elliot_Varmus.html   (365 words)

  
 The Harvard Crimson :: News :: Harold E. Varmus: Nobel Prize Catapults Researcher into Public Eye
While in Cambridge, Varmus worked in the cancer research laboratory of Robert Weindruck at the Whitehead Institute, an independent research laboratory that is affiliated with the Massachusetts Institute of Technology.
In October 1999, Varmus, who is now 61, announced he would leave NIH to become president and chief executive of the Memorial Sloan-Kettering Cancer Center in New York City, one of the nation's largest cancer hospitals.
Varmus declined to comment for this story, saying that he does not want to confuse people at Sloan-Kettering to whom he has made commitments.
www.thecrimson.com /article.aspx?ref=102923   (893 words)

  
 Harold E. Varmus - Wikipedia, the free encyclopedia
Harold Varmus biography from Memorial Sloan-Kettering Cancer Center
Harold Varmus profile from the Public Library of Science
Harold Varmus debates the Open Access journal model
en.wikipedia.org /wiki/Harold_E._Varmus   (197 words)

  
 genome.gov | 2005 Jeffrey M. Trent Lectureship in Cancer Research
Harold Varmus, former Director of NIH and co-recipient of a Nobel Prize for studies of the genetic basis of cancer, has served as the President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center in New York City since January 2000.
Varmus is also widely recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer, and the development of mouse models for human cancer (the focus of much of the current work in his laboratory at Memorial Sloan-Kettering Cancer Center).
In 1993, Varmus was named by President Clinton to serve as the Director of the National Institutes of Health, a position he held until the end of 1999.
www.genome.gov /16015022   (716 words)

  
 Harold Varmus, Lewis Branscomb are honored with the Vannevar Bush Award
Varmus is currently president of the Memorial Sloan-Kettering Cancer Center in New York City, the nation's oldest and largest private institution for cancer research.
Harold has opened many doors in education and has provided tremendous leadership to the nation's scientific community.
As a professor of microbiology, Varmus shared the Nobel Prize for Physiology or Medicine in 1989 with Professor J. Michael Bishop, his then colleague at the University of California, San Francisco, for their work in retroviruses that led to an understanding of the genetic basis for cancer.
www.eurekalert.org /pub_releases/2001-05/NSF-HVLB-0805101.php   (970 words)

  
 Harold Varmus speaks on "The Origins of Cancer"   (Site not responding. Last check: 2007-10-15)
Varmus has been director of the National Institutes of Health (NIH) in Bethesda, Md., since November of 1993, and he is the first Nobelist to serve as NIH director.
Varmus graduated from Amherst College (B.A. in English literature, 1961), Harvard University (M.A. in English literature, 1962) and Columbia University (M.D., 1966).
Varmus came to the University of California at San Francisco as a postdoctoral fellow in the laboratory of Dr. J.
www.news.cornell.edu /Chronicle/97/11.6.97/Varmus.html   (373 words)

  
 The Trustees: Harold Varmus   (Site not responding. Last check: 2007-10-15)
Harold Varmus, former Director of the National Institutes of Health and co-recipient of a Nobel Prize for studies of the genetic basis of cancer, has served as the President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center in New York City since January 2000.
In 1993, Varmus was named by President Clinton to serve as the Director of the National Institutes of Health, a position he held until the end of 1999.
A native of Freeport, Long Island, Varmus is a graduate of Columbia University's College of Physicians and Surgeons and served on the medical house staff at Columbia-Presbyterian Hospital.
www.columbia.edu /cu/secretary/trustees/bios/Varmus.html   (419 words)

  
 Public Library of Science: Board of Directors
Harold Varmus, former director of the National Institutes of Health (NIH) and co-recipient of a Nobel prize for studies of the genetic basis of cancer, currently serves as the president and chief executive officer of the Memorial Sloan-Kettering Cancer Center in New York City.
In 1993, Varmus was named by President Bill Clinton to serve as the director of the NIH, a position he held until his appointment as CEO of the Memorial Sloan-Kettering Cancer Center.
Varmus is married to Constance Casey, a journalist and horticulturist; their two sons, Jacob and Christopher, also live in New York City.
www.plos.org /about/board.html   (2536 words)

  
 NIH Director To Speak at Commencement
Harold Varmus, director of the National Institutes of Health (NIH) and an internationally recognized authority on retroviruses and the genetic basis of cancer, will be the principal speaker during the Afternoon Exercises at the University's 345th Commencement on Thursday, June 6.
Varmus has been at the center of this process as a scientist and as a leading public official.
Varmus received his bachelor's degree in 1961 from Amherst College, his master's in English literature in 1962 from Harvard, and his M.D. in 1966 from Columbia University.
www.news.harvard.edu /gazette/1996/04.04/NIHDirectorToSp.html   (511 words)

  
 Varmus, Harold
Varmus graduated from Amherst (Mass.) College (B.A.) in 1961, from Harvard University (M.A.) in 1962, and Columbia University, New York City (M.D.), in 1966.
Varmus remained on the faculty of the University of California, where he became a professor of biochemistry and biophysics in 1982.
Varmus and Bishop found that, under certain circumstances, normal genes in healthy cells of the body can cause cancer; these genes are termed oncogenes.
www.britannica.com /nobel/micro/618_48.html   (237 words)

  
 [No title]
And with that thought, Varmus redirected his curiosity first to medicine, then to science, and finally to running the largest biomedical institution in the world, the National Institutes of Health.
In 1957, Varmus began pre-med studies at Amherst College but was seduced by the academic life.
Varmus currently runs the Memorial Sloan-Kettering Cancer Center, where he is President and Chief Executive Officer, in New York City.
www.dnaftb.org /dnaftb/concept_40/con40bio.html   (1647 words)

  
 Caltech Press Release, 5/7/2003,
Much of Varmus' scientific work was conducted during 23 years as a faculty member at UC San Francisco, where he and J. Michael Bishop demonstrated the cellular origins of the oncogene of a chicken retrovirus.
Varmus is also widely recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer, and the development of mouse models for human cancer (the focus of much of the current work in his laboratory at Memorial Sloan-Kettering).
In 1993, Varmus was named by President Bill Clinton to serve as the director of the National Institutes of Health, a position he held until the end of 1999.
pr.caltech.edu /media/Press_Releases/PR12387.html   (605 words)

  
 AEGiS-GMHC: WASHINGTON WATCH: Harold Varmus
Varmus, a Nobel laureate cancer researcher from the University of California at San Francisco, will replace Bernadine Healy, MD, whose controversial tenure was marked by infighting at the agency, and just plain fighting on Capitol Hill.
Varmus co-signed the letter with Mark Kirschner, PhD, his colleague at UCSF, and sent it to 21 Massachusetts research scientists, urging them to sign, in turn, an enclosed letter to Senator Kennedy, the principal Senate sponsor of S.1, opposing the Title XVIII provisions.
(Varmus won the Nobel Prize with Bishop in 1989 for their discovery that oncogenes, cancer-causing genes found in many cells, are present in the human genetic code, and are not foreign intruders.) Though four other Nobel winners worked at the NIH, Varmus will be the first to head the agency.
www.aegis.com /pubs/gmhc/1993/GM070912.html   (1344 words)

  
 Grand Challenges in Global Health   (Site not responding. Last check: 2007-10-15)
Harold Varmus is the President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center in New York City.
Prior to this position, Dr. Varmus was appointed Director of the National Institutes of Health (NIH) by President Clinton, a position he held from 1993 until the end of 1999.
Varmus earned a master’s degree in English at Harvard University, and is a graduate of Columbia University’s College of Physicians and Surgeons.
www.grandchallengesgh.org /BioPrint.aspx?ID=1   (327 words)

  
 National Medal of Science Awarded to Dr. Harold Varmus
During his highly praised performance at the NIH, Dr. Varmus reinvigorated the nation's biomedical research enterprise, initiated many changes in the conduct of intramural and extramural research programs, recruited outstanding new leaders for many of the Institutes, and helped to increase the agency's annual budget from under $11 billion to nearly $18 billion.
Varmus also led a successful effort to obtain rezoning of the Center's Upper East Side campus, setting the stage for the construction of a new 23-story research facility, MSKCC's first new laboratory building in more than a decade.
Varmus has co-authored more than 300 scientific papers and four books, including an introduction to the genetic basis of cancer, Genes and the Biology of Cancer, for a general audience.
www.charitywire.com /charity95/03586.html   (590 words)

  
 The Rockefeller University - Events
Harold Varmus, president of Memorial Sloan-Kettering Cancer Center, is a world-renowned authority on the molecular basis of cancer.
Varmus also is widely recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer and the development of mouse models for human cancer (the focus of much of the current work in his laboratory at MSKCC).
In 1993, President Bill Clinton appointed Varmus to serve as the director of the National Institutes of Health, a position he held until the end of 1999, when he became president of MSKCC.
www.rockefeller.edu /lectures/050302.html   (264 words)

  
 DOCUMENTS IN THE GALLO CASE:Correspondence
Harold Varmus, Director National Institutes of Health Dear Dr. Varmus: We enclose here a draft report on an investigation of the Gallo case by the staff of a subcommittee headed by Congressman John Dingell.
The gravity of your action is reflected by the fact that Representative John Dingell saw fit to write NIH Director Harold Varmus a letter indicating that the report you distributed was not an official congressional report.
Your Letters of Reprimand state: The gravity of your action is reflected by the fact that Representative John Dingell saw fit to write NIH Director Harold Varmus a letter indicating that the report you distributed was not an official congressional report.
www.healtoronto.com /gallocor.html   (12342 words)

  
 Evaluating the Burden of Disease and Spending the Research Dollars of the National Institutes of Health
Varmus notes that due to a strong record of accomplishments, NIH has received generous federal funding.
Varmus says that the method of calculating the cost of disability adjusted life years has some limitations in terms of specificity.
In conclusion, Varmus notes that NIH has established an NIH office of public liaison, with similar offices in each center, and a Director's Council of Public Representatives.
www.aegis.com /news/ads/1999/AD990995.html   (555 words)

  
 [No title]
Varmus acknowledged to the panel that “sensitivity or standards regarding potential conflicts of interest must be heightened when decisions affecting research on humans is involved.” Not discussed by the panel is the culture that emerged within NIH as business ethics prevailed.
Varmus at that time also jettisoned a $25,000 annual cap on the amount of money that an NIH employee could accept from outside employers and a limit of 500 hours a year on outside activities.
Varmus said Friday that he had concluded that institute directors, deputy directors, scientific directors and clinical directors should be required to file yearly income reports that are open to the public.
www.drugawareness.org /Archives/1stQtr_2004/record0023.html   (1509 words)

  
 Fox Chase Cancer Center: News 2000 - Varmus to Deliver Keynote Address   (Site not responding. Last check: 2007-10-15)
Harold Varmus, former Director of the National Institutes of Health and co-recipient of the Nobel Prize for studies of the genetic basis of cancer, is currently the president and chief executive officer of Memorial Sloan-Kettering Cancer Center in New York City.
Varmus won the Nobel Prize for Physiology or Medicine for work he did as a faculty member at the University of California, San Francisco.
In 1993, Dr. Varmus was named by President Clinton to serve as the Director of the National Institutes of Health, a position he held until the end of 1999 when he left to become CEO of Memorial Sloan-Kettering.
www.fccc.edu /news/2000/Postdoc-Fellow-Conference-06-05-2000.html   (389 words)

  
 The Sentinel Online - Archived Story
Varmus and Nobel Prize winner Dr. Sidney Altman belong to "Scientists and Engineers For Change," formed to show the impact the 2004 presidential election could have on the future of U.S. science and technology.
Varmus, who served as director of the National Institutes of Health under former President Bill Clinton, says he's witnessed a "real denial in facts" when the current administration tackles scientific issues.
Altman and Varmus say regardless of religious or political beliefs, it's important for the American people to consider the scientific discovery process and how they want science to be developed in years to come.
www.cumberlink.com /articles/2004/10/23/news/news01.txt   (770 words)

  
 Columbia Magazine
Varmus, president and chief executive officer of New York’s Memorial Sloan-Kettering Cancer Center, is one of the world’s foremost cancer researchers.
Harold Varmus, M.D. Last June President George W. Bush awarded Varmus the National Medal of Science, the nation’s highest honor for achievement in science and technology.
Varmus is the author of more than 300 scientific papers, as well as four books, including Genes and the Biology of Cancer, an introduction to the genetic basis of cancer written for a general audience.
www.columbia.edu /cu/alumni/Magazine/Fall2002/Trustees.html   (443 words)

  
 [No title]   (Site not responding. Last check: 2007-10-15)
Biography: Before being sworn in as the Director of the NIH, Dr. Varmus was a Professor of Microbiology and Immunology and Biochemistry and Biophysics, and the American Cancer Society Professor of Molecular Virology at the University of California, San Francisco, (UCSF), where he studied retroviruses and the genetic basis of cancer for over 20 years.
Varmus is a member of the Institute of Medicine, the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Association of Physicians.
Varmus left NIH at the beginning of this year to accept a job as the President of Memorial Sloan-Kettering Cancer Center in New York City.
rex.nci.nih.gov /RESEARCH/basic/varmus/hevbio.html   (225 words)

  
 AAMC News Room: Press Releases: NRMP To Include Pediatric Critical Care Medicine Speciality Match - 10/6/99
Harold Varmus, M.D., will be remembered as one of the great NIH directors and forever linked with the explosion of scientific knowledge and promise synonymous with the decade of the 1990s.
Varmus' contributions are many and lasting, from his adept handling of the political minefields of science policy, to his appointment of a first-class NIH leadership team, to his ability to effectively communicate the wonders of science to the public, and, finally, to the expansion of the NIH budget from $10 billion to nearly $16 billion.
While we are disappointed that Dr. Varmus' NIH directorship has come to an end, we are pleased that he will continue as a leader and prominent spokesperson for the American scientific community while at the Memorial Sloan-Kettering Cancer Center.
www.aamc.org /newsroom/pressrel/1999/991007.htm   (230 words)

Try your search on: Qwika (all wikis)

Factbites
  About us   |   Why use us?   |   Reviews   |   Press   |   Contact us  
Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.